Schering-Plough Clarinex NDA Approval Awaits Resolution Of GMP Problems

Schering-Plough's Clarinex (desloratadine) NDA will not be approved until the company answers FDA concerns regarding Good Manufacturing Practices compliance at a wide range of Schering operations.